More on KALV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (3/12/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

KalVista Pharmaceuticals (NQ:KALV)
Delayed: 16.23 +0.02 (0.12%)
Prev. Close $16.21  
Open$16.00 
52 Wk High$ 
52 Wk Low$ 
Day High$16.36 
Day Low$15.73 
P/E N/A  
EPS$ 
Volume671,540 

Friends, Peers and Foes (?): MGX, ARGX, OCUL, VRTX, ARWR (more...)

Mar 4, 2026 07:00 AM KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 2, 2026 07:01 AM KalVista presents data showing high patient preference for oral HAE drug
Mar 2, 2026 07:00 AM KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat)
Feb 25, 2026 07:00 AM KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 24, 2026 07:45 PM Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Audhya Paul K.
Feb 24, 2026 07:44 PM Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Palleiko Benjamin L
Feb 24, 2026 07:43 PM Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Yea Christopher
Feb 24, 2026 07:43 PM Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Sweeny Nicole
Feb 24, 2026 07:42 PM Form 4 KalVista Pharmaceuticals For: Feb 21 Filed by: Piekos Brian
Feb 19, 2026 07:45 PM Form 4 KalVista Pharmaceuticals For: Feb 17 Filed by: Palleiko Benjamin L
View All Articles

Entities mentioned with KALV

View All Entities